TherapeuticsMD Inc (TXMD): Keep in mind that: 1) TXMD has filed...

S&P 500

US TECH 100

Dow Jones

Brent Oil

Bitcoin

TherapeuticsMD Inc (TXMD)

Reply Private New

Keep Last Read

Next 10 Prev Next

Send PM Follow Ignore

Followers	109
Posts	8813
Boards Moderated	0
Alias Born	08/03/2004

Re: None

Tuesday, 12/08/2015 10:00:50 AM

Tuesday, December 08, 2015 10:00:50 AM

Keep in mind that:

1) TXMD has filed an EFFECT on their S-3 Registration last month.

http://www.sec.gov/Archives/edgar/data/25743/999999999515003075/9999999995-15-003075-index.htm

2) The last 10Q shows 177,848,041 shares as of November 2, 2015.

With that being said: Happy Hunting!

It is, what it is.

Keep Last Read

Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

1D
1M
3M
6M
1Y
5Y

Detailed Quote

Recent TXMD News

TherapeuticsMD Announces Full Year 2023 Financial Results • Business Wire • 03/29/2024 08:00:00 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/07/2023 09:51:56 PM
Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 12/06/2023 04:36:35 PM
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 11/17/2023 02:28:51 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/17/2023 02:27:23 PM
TherapeuticsMD Announces Third Quarter 2023 Financial Results • Business Wire • 11/14/2023 09:05:00 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/21/2023 08:22:58 PM
Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 08/21/2023 08:20:09 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/18/2023 09:18:30 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 11:30:59 AM
Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2023 11:15:28 AM
TherapeuticsMD Announces Second Quarter 2023 Financial Results • Business Wire • 08/14/2023 10:50:00 AM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/19/2023 09:29:57 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/19/2023 09:28:26 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/19/2023 09:27:06 PM
Form 8-K - Current report • Edgar (US Regulatory) • 07/10/2023 09:20:29 PM
Form 8-K - Current report • Edgar (US Regulatory) • 07/06/2023 08:38:59 PM
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 06/30/2023 12:29:16 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/29/2023 09:21:32 PM
TherapeuticsMD Announces First Quarter 2023 Financial Results • Business Wire • 05/15/2023 08:05:00 PM

More TXMD News

InvestorsHub NewsWire

NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM

Start posting your company's news

Only $200 per official company press release!

InvestorsHub community

Register for free to join our community of investors and share your ideas

You'll also get access to streaming quotes, interactive charts, trades, portfolio, live options flow